Continuous Renal Replacement Therapy Industry to Witness 10.9% Growth, Reaching $2.64 Billion by 2029
The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.
Get Your Free Sample of The Global Continuous Renal Replacement Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15777&type=smp
Which Market drivers have played a significant role in driving the continuous renal replacement therapy market?
The increasing incidence of chronic kidney diseases is expected to propel the growth of the continuous renal replacement therapy market going forward. Chronic kidney disease (CKD) is a long-term condition where the kidneys progressively lose function over time, leading to impaired filtration of waste products from the blood. The rising incidence of chronic kidney diseases is influenced by lifestyle changes, aging populations, and increasing rates of diabetes and hypertension. Continuous renal replacement therapy is utilized in chronic kidney disease for acute exacerbations or complications to manage fluid balance and continuously remove metabolic waste products. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a U.S.-based national public health agency, more than 1 in 7 adults in the US, over 35.5 million people, are estimated to have chronic kidney disease (CKD). Notably, nearly 90% of these individuals remain unaware of their condition, underscoring a significant gap in early detection and awareness efforts for CKD in the US. Therefore, the increasing incidence of chronic kidney diseases is driving the growth of the continuous renal replacement therapy market.
What are the key segments within the continuous renal replacement therapy market?
The continuous renal replacement therapy market covered in this report is segmented –
1) By Product: System, Consumables
2) By Therapy: Renal, Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults, Pediatrics Or Neonates
5) By End-Users: Hospitals, Ambulatory Care, Homecare
Subsegments:
1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets
2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/continuous-renal-replacement-therapy-global-market-report
Which key players are shaping the continuous renal replacement therapy market?
Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.
Which transformative trends will shape the continuous renal replacement therapy market landscape?
Major companies operating in the continuous renal replacement therapy market are focused on developing innovative renal therapy options for dialysis patients to enhance treatment efficacy, improve patient outcomes, and reduce complications associated with traditional dialysis methods. This innovative therapy operates continuously, typically over 24 hours, and is gentler on the body compared to standard dialysis, making it suitable for patients with acute kidney injuries or severe health conditions. For instance, in January 2023, according to a report published by Peconic Bay Medical Center (PBMC), a US-based medical center that offers medical services, including emergency care and, surgical services, launched a new renal therapy option for dialysis patients. The therapy is designed to be more comfortable for patients who may not tolerate standard dialysis due to their medical conditions. CRRT is administered more slowly than traditional dialysis, which helps minimize stress on critically ill patients..
How do regional factors impact the continuous renal replacement therapy market, and which region is the largest contributor?
North America was the largest region in the continuous renal replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Continuous Renal Replacement Therapy Market Report 2025 Offer?
The continuous renal replacement therapy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Continuous renal replacement therapy (CRRT) is a type of dialysis that provides slow, continuous blood filtration to help regulate fluid, electrolyte, and waste levels in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It helps manage fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal by intermittent hemodialysis due to cardiovascular instability.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15777
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment